Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Cholesterol

Q: Do eggs raise my cholesterol?

On average, dietary cholesterol has a modest effect on blood LDL. Some people are hyper-responders and should limit intake; others see little change.

Q: Is there a cholesterol supplement?

No clinical use for cholesterol pills exists. Most people aim to lower, not raise, blood cholesterol.

Fatty-acidSterol

An essential lipid, not a supplement. The body makes ~1 g/day of its own cholesterol (HMG-CoA reductase, the statin target) and absorbs another ~300 mg from animal foods. It's the substrate for steroid hormones, bile acids, vitamin D, and every cell membrane. Modern dietary guidelines (2015 DGA, 2020 AHA) recognize dietary cholesterol as a modest contributor to serum LDL for most people — saturated fat, genetics, and total dietary pattern matter more. Cardiovascular risk is managed by lowering LDL, not by avoiding dietary cholesterol per se.

Quick decision guide

May help most

Understanding the biology behind heart-disease prevention — not something to supplement. Adults concerned about cardiovascular risk should focus on overall dietary pattern, saturated fat, body weight, exercise, blood pressure, and (for some) statin therapy guided by a clinician.

Common dosing range

Not a supplement. Dietary cholesterol intake is naturally 100–500 mg/day on omnivorous diets. The 2015 DGA removed the prior 300 mg/day cap; AHA 2020 recommends keeping dietary cholesterol 'as low as possible within a healthy eating pattern' but did not reinstate a numerical limit.

When to expect effects

Lipid panel changes appear in weeks; clinical event risk reduction (from statin or other LDL-lowering therapy) accrues over years.

Watch out for

Hyperresponders (~25% of adults) have meaningful LDL rises with high dietary cholesterol — egg studies show variable response. People with familial hypercholesterolemia have lifelong markedly elevated LDL regardless of diet and need pharmacological treatment.

Evidence snapshot

Cholesterol's role in human biologyStrong

Dietary cholesterol → serum LDL (most people)Modest

LDL-lowering therapy → CV event reductionStrong

Familial hypercholesterolemia → early ASCVDStrong

What is it

Cholesterol is a waxy lipid molecule made by the liver and obtained from animal-source foods. It is a precursor for steroid hormones, bile acids, and vitamin D, and is a structural component of cell membranes.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want to understand the biology before changing your diet or starting a statin

You have a family history of early heart disease — get lipid screening; ask about familial hypercholesterolemia

You have an elevated LDL-cholesterol on a routine lipid panel — focus on dietary pattern, weight, exercise, and discuss statin/non-statin therapy with your clinician

You are a 'hyperresponder' to dietary cholesterol (your LDL clearly rises when you eat more eggs / shellfish / organ meats) — moderating intake is reasonable

Probably skip if…

You are looking for a cholesterol 'supplement' to take — there isn't one; this is body chemistry

You are healthy with normal LDL and a varied diet — avoiding eggs or shellfish on principle has no evidence base in the 2015 DGA / AHA 2020 framing

You are looking for evidence that 'cholesterol doesn't matter' — LDL-particle and LDL-cholesterol are causal in atherosclerosis; statin trials are the bedrock cardiovascular evidence

You want to self-manage clearly elevated LDL with diet alone in the setting of established CV disease or diabetes — guideline-directed pharmacotherapy is what reduces hard outcomes

Evidence at a glance

Goal	Effect	Best fit	Time
Membrane structure, hormone synthesis, bile acid synthesis Strong Evidence	Essential biological role; not a 'benefit' of supplementation	Universally required by human biology	N/A
Familial hypercholesterolemia recognition and treatment Strong Evidence	Statin therapy in FH reduces CV events >70% over decades	Anyone with LDL >190 mg/dL untreated, premature family history of CAD, or a known FH variant	LDL responds in weeks; event-reduction benefit accrues over decades
Cardiovascular event reduction via LDL lowering (statins, etc.) Strong Evidence	Roughly 20–25% reduction in major CV events per ~38 mg/dL (1 mmol/L) LDL reduction sustained for ~5 years	Adults meeting 2019 ACC/AHA primary or secondary prevention criteria, evaluated by a clinician	LDL change in weeks; event-reduction benefit accrues over years
Dietary cholesterol and serum LDL (for most people) Limited Evidence	Modest LDL impact in most adults; meaningful in ~25% hyperresponders	General adult population without familial hypercholesterolemia	Weeks for lipid panel change after sustained dietary shift

Membrane structure, hormone synthesis, bile acid synthesis

Strong Evidence

Effect: Essential biological role; not a 'benefit' of supplementation
Best fit: Universally required by human biology
Time: N/A

Familial hypercholesterolemia recognition and treatment

Strong Evidence

Effect: Statin therapy in FH reduces CV events >70% over decades
Best fit: Anyone with LDL >190 mg/dL untreated, premature family history of CAD, or a known FH variant
Time: LDL responds in weeks; event-reduction benefit accrues over decades

Cardiovascular event reduction via LDL lowering (statins, etc.)

Strong Evidence

Effect: Roughly 20–25% reduction in major CV events per ~38 mg/dL (1 mmol/L) LDL reduction sustained for ~5 years
Best fit: Adults meeting 2019 ACC/AHA primary or secondary prevention criteria, evaluated by a clinician
Time: LDL change in weeks; event-reduction benefit accrues over years

Dietary cholesterol and serum LDL (for most people)

Limited Evidence

Effect: Modest LDL impact in most adults; meaningful in ~25% hyperresponders
Best fit: General adult population without familial hypercholesterolemia
Time: Weeks for lipid panel change after sustained dietary shift

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Membrane structure, hormone synthesis, bile acid synthesis

Mechanism only

Strong Evidence

Cholesterol is structurally essential — every cell membrane contains it (~30% of plasma membrane lipid weight), where it regulates fluidity and forms lipid rafts. It is the obligate precursor for all steroid hormones (cortisol, aldosterone, testosterone, estradiol, progesterone), bile acids (for fat digestion), and the vitamin D precursor 7-dehydrocholesterol in skin. There is no scenario in which a person produces too little cholesterol from natural biology — the body tightly autoregulates synthesis (HMG-CoA reductase) and absorption (NPC1L1) to maintain supply.

Effect size

Essential biological role; not a 'benefit' of supplementation

Time to effect

N/A

Best fit

Universally required by human biology

Less likely

Not applicable — not a supplement

Bottom line: Cholesterol is essential body chemistry — no one needs to supplement it.

SourceCholesterol synthesis context (NIH) — NIH NCBI Bookshelf / Biochemistry, 5th edition (Berg)NIH NHLBI — High Blood Cholesterol — National Heart, Lung, and Blood Institute

Familial hypercholesterolemia recognition and treatment

Disease adjunct

Strong Evidence

Familial hypercholesterolemia (FH) is an autosomal-codominant disorder affecting ~1 in 250 people — vastly under-diagnosed. LDL is elevated from birth (typically >190 mg/dL in adults, >160 mg/dL in children). Untreated FH causes very early coronary disease: heart attacks in men in their 40s, women in their 50s. Statin therapy from young adulthood reduces cardiovascular events by >70%. Universal pediatric and adult lipid screening is recommended; cascade family screening once a case is identified.

Effect size

Statin therapy in FH reduces CV events >70% over decades

Time to effect

LDL responds in weeks; event-reduction benefit accrues over decades

Best fit

Anyone with LDL >190 mg/dL untreated, premature family history of CAD, or a known FH variant

Less likely

Adults with normal LDL and no family history

Bottom line: FH is under-diagnosed and dramatically responsive to statin therapy. Get screened if family history fits.

SourceNordestgaard et al., 2013 (Consensus Statement) — European Heart Journal

Cardiovascular event reduction via LDL lowering (statins, etc.)

Disease adjunct

Strong Evidence

Decades of large RCTs (4S, WOSCOPS, HPS, JUPITER, IMPROVE-IT, FOURIER, ODYSSEY) establish that lowering LDL with statins, ezetimibe, or PCSK9 inhibitors reduces cardiovascular events approximately in proportion to the LDL reduction achieved. The 2019 ACC/AHA Primary Prevention Guideline recommends statins for adults 40–75 with diabetes, LDL ≥190 mg/dL, or 10-year ASCVD risk ≥7.5%. The pharmacological lever — not the dietary-cholesterol lever — is what drives clinical event reduction.

Effect size

Roughly 20–25% reduction in major CV events per ~38 mg/dL (1 mmol/L) LDL reduction sustained for ~5 years

Time to effect

LDL change in weeks; event-reduction benefit accrues over years

Best fit

Adults meeting 2019 ACC/AHA primary or secondary prevention criteria, evaluated by a clinician

Less likely

Adults with very low LDL and no risk factors — number-needed-to-treat is high

Bottom line: Statin (and other LDL-lowering) therapy is the evidence-based lever, not dietary cholesterol avoidance.

SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

Dietary cholesterol and serum LDL (for most people)

Biomarker support

Limited Evidence

The 2015 Dietary Guidelines for Americans removed the prior 300 mg/day limit on dietary cholesterol, citing evidence that for most adults the relationship between cholesterol intake and serum LDL is small relative to the impact of saturated fat, body weight, and genetics. The 2020 AHA Presidential Advisory reaffirmed this but advised keeping dietary cholesterol 'as low as possible within a healthy eating pattern' without specifying a number. A subset (~25%) are 'hyperresponders' whose LDL rises meaningfully with dietary cholesterol changes — APOE4 carriers are over-represented in this group.

Effect size

Modest LDL impact in most adults; meaningful in ~25% hyperresponders

Time to effect

Weeks for lipid panel change after sustained dietary shift

Best fit

General adult population without familial hypercholesterolemia

Less likely

Hyperresponders, people with established cardiovascular disease, people with FH — different rules apply

Bottom line: For most people, dietary cholesterol is not the main lever for LDL. Saturated fat, body weight, exercise, and overall pattern matter more.

Evidence is mixed

The decades-long 'avoid all dietary cholesterol' message has been substantially walked back by both the 2015 DGA and the 2020 AHA advisory. Modern emphasis is on overall dietary pattern (Mediterranean, DASH) and saturated fat, not on a numerical cholesterol cap. Hyperresponder subset complicates one-size-fits-all messaging.

Source2015–2020 Dietary Guidelines for Americans — USDA & HHS· conflicting Carson et al. (AHA Presidential Advisory), 2020 — Circulation· conflicting Fernandez, 2012 — Current Opinion in Clinical Nutrition and Metabolic Care

Source2015–2020 Dietary Guidelines for Americans — USDA & HHS Carson et al. (AHA Presidential Advisory), 2020 — Circulation Fernandez, 2012 — Current Opinion in Clinical Nutrition and Metabolic Care Berger et al., 2015 — American Journal of Clinical Nutrition

How it works

Dietary cholesterol is absorbed in the small intestine via the NPC1L1 transporter and packaged into chylomicrons. Endogenous cholesterol is synthesized by the liver through the HMG-CoA reductase pathway. Circulating cholesterol is transported in lipoprotein particles (LDL, HDL, VLDL). LDL delivers cholesterol to peripheral tissues; HDL returns excess cholesterol to the liver for excretion in bile. For most healthy adults, dietary cholesterol has a modest effect on blood cholesterol because the liver downregulates synthesis in response to intake. A subset of people are 'hyper-responders' whose LDL rises significantly with dietary cholesterol.

How to take it

1. Typical dose

• Cholesterol is not a supplement — there is no recommended dietary 'dose' • Most adults: focus on overall dietary pattern (Mediterranean, DASH), saturated fat <10% calories, weight management • If you are a hyperresponder (your LDL clearly rises with dietary cholesterol): moderate egg, shellfish, organ meat intake and recheck lipids

2. Higher studied dose

Not applicable — see your clinician for evidence-based LDL-lowering therapy (statin, ezetimibe, PCSK9 inhibitor) when indicated.

3. Timing

Not applicable. Statins are typically dosed evening (atorvastatin, rosuvastatin can be any time; simvastatin, lovastatin evening because of hepatic synthesis circadian rhythm).

4. With food

Not applicable to dietary cholesterol per se. Statins: check the specific drug label for food guidance.

5. Split dosing

Not applicable.

6. How long to try

Cardiovascular risk-factor management is lifelong. Lipid panel every 4–6 years for low-risk adults; more frequently if on therapy or at higher risk.

What to track

Lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C) at clinician-recommended intervals

Apolipoprotein B (apoB) and Lp(a) for refined risk assessment when LDL is borderline or family history is concerning

Coronary artery calcium (CAC) score in adults 40–75 with intermediate ASCVD risk to refine statin decision

Blood pressure, weight, A1c, smoking status — bigger drivers of CV risk than dietary cholesterol for most people

Family history of premature CAD — anyone first-degree relative with CAD before age 55 (men) / 65 (women) warrants careful lipid screening

Bottom line: Don't 'dose' cholesterol. Manage cardiovascular risk through dietary pattern, weight, exercise, BP, and clinician-guided lipid-lowering therapy when indicated.

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Dietary cholesterol (animal foods)

From food

Cholesterol from animal source foods: eggs (~185 mg per large yolk), shellfish (especially shrimp and squid), liver and other organ meats (very high), butter and full-fat dairy, meat and poultry. Plant foods contain essentially no cholesterol (plant sterols are different molecules).

Absorption ~30–80% across individuals; downregulates endogenous synthesis.

Endogenous cholesterol (made by the liver and other tissues)

Body's own supply

Synthesized de novo via the mevalonate pathway from acetyl-CoA. HMG-CoA reductase is the rate-limiting enzyme (and the target of statin drugs). Daily synthesis ~1 g, mostly in the liver; downregulated when dietary intake rises.

Lipoprotein-bound cholesterol (LDL, HDL, VLDL, IDL)

How it circulates

Cholesterol travels in blood inside lipoprotein particles. LDL ('bad') delivers cholesterol to peripheral tissues; HDL ('good') returns it to liver. Atherosclerosis is driven by LDL-particle (apoB-containing) deposition in arterial walls.

Lipid panel quantifies LDL-C, HDL-C, total cholesterol, triglycerides; apoB and Lp(a) refine risk.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

not applicable — cholesterol is endogenous body chemistry

Serious risks

Markedly elevated LDL (≥190 mg/dL) often indicates familial hypercholesterolemia and is associated with very early coronary artery disease if untreated. Get screened; consider cascade family screening.
SourceNordestgaard et al., 2013 (Consensus Statement) — European Heart Journal
Statin myopathy (muscle aches) is the most common side effect of statin therapy — usually mild and reversible. Rhabdomyolysis is rare; discuss with your clinician if persistent muscle pain.
SourceACC/AHA 2019 Primary Prevention Guideline — Circulation
Very low cholesterol (LDL <40 mg/dL on aggressive therapy or in untreated abetalipoproteinemia / hypobetalipoproteinemia) was historically a concern; large statin trials have not shown safety signals at very low LDL.
SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

Who should avoid it

Not applicable — you cannot 'avoid' cholesterol, your body makes it. The question is whether to limit dietary cholesterol, which depends on individual hyperresponder status and overall risk profile.
People with abetalipoproteinemia or other rare lipid-malabsorption disorders need specialist management — do not extrapolate general adult guidance.

Pregnancy & breastfeeding

Cholesterol naturally rises during pregnancy (placental steroid synthesis). Statins are contraindicated during pregnancy and breastfeeding due to fetal-development concerns. Lifestyle measures and PCSK9 inhibitors (specialist-guided) may be considered for very-high-risk pregnant patients with familial hypercholesterolemia.

SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

Bottom line: Cholesterol is body chemistry, not a supplement. Focus on managing cardiovascular risk via diet, weight, BP, exercise, and clinician-guided lipid therapy when indicated.

Interactions

statins (atorvastatin, rosuvastatin, simvastatin, pravastatin, lovastatin)Minor

Statins inhibit HMG-CoA reductase to lower endogenous cholesterol synthesis. Dietary cholesterol matters less when synthesis is suppressed; total dietary pattern still matters for non-cholesterol risk factors.

SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

ezetimibeMinor

Ezetimibe inhibits intestinal NPC1L1 cholesterol absorption. Dietary cholesterol absorption is blunted; effect on overall LDL is modest (~−15–18%).

SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

bile acid sequestrants (cholestyramine, colesevelam)Minor

Sequester bile acids in the gut, forcing the liver to make more from cholesterol and lower serum LDL. Can also bind other oral medications — separate dosing.

PCSK9 inhibitors (alirocumab, evolocumab)Minor

Monoclonal antibodies that increase hepatic LDL-receptor recycling, dramatically lowering LDL (50–60%). Reserved for high-risk patients on statin and ezetimibe who need further LDL reduction.

SourceACC/AHA 2019 Primary Prevention Guideline — Circulation

Food sources

Food	Amount	%DV
Egg, whole large	1 large egg (~185 mg cholesterol, all in yolk)	62%
Beef liver, cooked	3 oz (~324 mg cholesterol)	108%
Shrimp, cooked	3 oz (~166 mg cholesterol)	55%
Squid, fried	3 oz (~221 mg cholesterol)	74%
Butter	1 tbsp (~31 mg cholesterol)	10%
Cheddar cheese	1 oz (~30 mg cholesterol)	10%
Beef, ground 80%, cooked	3 oz (~77 mg cholesterol)	26%
Chicken breast, roasted, skinless	3 oz (~73 mg cholesterol)	24%
Salmon, Atlantic, cooked	3 oz (~54 mg cholesterol)	18%
Whole milk	1 cup (~24 mg cholesterol)	8%
Plant foods (fruits, vegetables, grains, nuts, legumes)	0 mg cholesterol — only animals make cholesterol	0%

Egg, whole large

Amount: 1 large egg (~185 mg cholesterol, all in yolk)
%DV: 62%

Beef liver, cooked

Amount: 3 oz (~324 mg cholesterol)
%DV: 108%

Shrimp, cooked

Amount: 3 oz (~166 mg cholesterol)
%DV: 55%

Squid, fried

Amount: 3 oz (~221 mg cholesterol)
%DV: 74%

Butter

Amount: 1 tbsp (~31 mg cholesterol)
%DV: 10%

Cheddar cheese

Amount: 1 oz (~30 mg cholesterol)
%DV: 10%

Beef, ground 80%, cooked

Amount: 3 oz (~77 mg cholesterol)
%DV: 26%

Chicken breast, roasted, skinless

Amount: 3 oz (~73 mg cholesterol)
%DV: 24%

Salmon, Atlantic, cooked

Amount: 3 oz (~54 mg cholesterol)
%DV: 18%

Whole milk

Amount: 1 cup (~24 mg cholesterol)
%DV: 8%

Plant foods (fruits, vegetables, grains, nuts, legumes)

Amount: 0 mg cholesterol — only animals make cholesterol
%DV: 0%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

There is no 'cholesterol supplement' — anything labelled as such is misframed

If your goal is LDL lowering: third-party tested soluble-fiber products (psyllium, oat/barley beta-glucan), plant stanols/sterols, and red yeast rice (essentially OTC lovastatin) have some evidence — but discuss with your clinician, not just rely on supplements

If your goal is general cardiovascular health: dietary pattern, exercise, BP, weight, smoking cessation, and statin-when-indicated — not single-ingredient supplements

Be skeptical of…

'Lowers cholesterol naturally — no statin needed' products targeting people with high CV risk who would benefit from guideline-directed therapy

'Cholesterol is harmless / saturated fat is harmless' contrarian framing that ignores RCT evidence on LDL-event reduction

Mega-dose red yeast rice products without clinician oversight — same risks as low-dose statins, plus product-quality variability

Egg / shellfish 'avoid at all costs' messaging that ignores the 2015 DGA / 2020 AHA modern framing

'High HDL is always good' messaging — large RCTs of HDL-raising drugs (niacin, CETP inhibitors except anacetrapib) have not shown CV benefit

Frequently asked questions

Do eggs raise my cholesterol?⌄

On average, dietary cholesterol has a modest effect on blood LDL. Some people are hyper-responders and should limit intake; others see little change.

Is there a cholesterol supplement?⌄

No clinical use for cholesterol pills exists. Most people aim to lower, not raise, blood cholesterol.

References by claim

Dietary cholesterol and serum LDL (for most people)

Carson et al. (AHA Presidential Advisory), 2020 — Circulation (2020) link

2015–2020 Dietary Guidelines for Americans — USDA & HHS (2015) link

Fernandez, 2012 — Current Opinion in Clinical Nutrition and Metabolic Care (2012) link

Berger et al., 2015 — American Journal of Clinical Nutrition (2015) link

Cardiovascular event reduction via LDL lowering (statins, etc.)

ACC/AHA 2019 Primary Prevention Guideline — Circulation (2019) link

Familial hypercholesterolemia recognition and treatment

Nordestgaard et al., 2013 (Consensus Statement) — European Heart Journal (2013) link

Membrane structure, hormone synthesis, bile acid synthesis

NIH NHLBI — High Blood Cholesterol — National Heart, Lung, and Blood Institute (2024) link

Cholesterol synthesis context (NIH) — NIH NCBI Bookshelf / Biochemistry, 5th edition (Berg) (2002) link

Track Cholesterol with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.